Uguz and colleagues showed that psychiatric disorders were identified less frequently in patients with RA receiving anti-TNF compared to patients who did not receive such medications [6], and a significant decrease in depression has been reported in patients with AS who receive anti-TNF [53]. The gene discussed is TNF; the disease is major depressive disorder.